Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Swartz Robin
COO & CBO at Voyager Therapeutics. Filing since 21 Mar 2022.
CIK 0001909636
Company
Date
Role
Action
Shares
Amount
Of holding
VYGR
Voyager Therapeutics, Inc.
24 Feb 2026
COO & CBO
Sold on a plan
6,458
$24.35K
3.1%
VYGR
Voyager Therapeutics, Inc.
18 Feb 2026
COO & CBO
Sold on a plan
3,882
$13.35K
1.8%
VYGR
Voyager Therapeutics, Inc.
10 Feb 2026
COO & CBO
Sold at will
4,569
$17.59K
2.1%
VYGR
Voyager Therapeutics, Inc.
20 Feb 2025
COO & CBO
Sold at will
3,894
$16.55K
3.8%
VYGR
Voyager Therapeutics, Inc.
11 Feb 2025
COO & CBO
Sold at will
6,950
$30.93K
6.4%
VYGR
Voyager Therapeutics, Inc.
14 Jan 2025
COO & CBO
Sold at will
3,087
$15.71K
2.7%
VYGR
Voyager Therapeutics, Inc.
23 Dec 2024
COO&CBO
Sold at will
6,500
$36.73K
5.5%
VYGR
Voyager Therapeutics, Inc.
2 Apr 2024
Chief Operating Officer
Sold at will
1,357
$13.41K
1.1%
VYGR
Voyager Therapeutics, Inc.
21 Feb 2024
Chief Operating Officer
Sold at will
3,966
$29.55K
3.2%
VYGR
Voyager Therapeutics, Inc.
17 Jan 2024
Chief Operating Officer
Sold at will
2,543
$18.18K
3.4%
VYGR
Voyager Therapeutics, Inc.
3 Apr 2023
Chief Operating Officer
Sold at will
1,259
$9.86K
1.7%
VYGR
Voyager Therapeutics, Inc.
20 Mar 2023
Chief Operating Officer
Sold at will
3,654
$28.36K
4.8%
VYGR
Voyager Therapeutics, Inc.
15 Mar 2023
Chief Operating Officer
Sold, plan not stated
15,373
$126.06K
16.7%
VYGR
Voyager Therapeutics, Inc.
17 Jan 2023
Chief Operating Officer
Sold, plan not stated
2,188
$21.55K
4.0%
VYGR
Voyager Therapeutics, Inc.
4 Apr 2022
Chief Operating Officer
Sold, plan not stated
1,527
$12.60K
2.8%
VYGR
Voyager Therapeutics, Inc.
21 Mar 2022
Chief Operating Officer
Sold, plan not stated
4,413
$36.60K
7.6%
16 decisions on file.
